Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis

BLOOD CANCER JOURNAL

NATURE PUBLISHING GROUP

1. Hellenic Society of Medical Oncology (HeSMO)
2. Black Swan Research Initiative of the International Myeloma Foundation
3. Spanish Instituto de Salud Carlos III/Subdireccion General de Investigacion Sanitaria [FIS: PI13/02196]